To evaluate the efficacy and safety of unani drug in ihtibas e tams(Ammenorrhoea)
Not Applicable
Completed
- Conditions
- Health Condition 1: N911- Secondary amenorrhea
- Registration Number
- CTRI/2022/11/047144
- Lead Sponsor
- central council for research in unani medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Women of age group 18-45 years complaining of absence of menstruation for last 3 or more months
Exclusion Criteria
1.Pregnancy
2.Lactation
3.Menopause
4.Primary amenorrhoea
5.Tumours
6.Patients with gross structural abnormalities of uterus, thyroid disease
7.Congenital abnormalities
8.Patients with abnormal prolactin,
abnormal thyroid function tests.
9 clinically significant diseases that might have limited participation in or completion of the study including any anatomical abnormality or gynaecological neoplasia severe drug allergy
10.Intake of any hormonal products (chemical or herbal) in the previous 2 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ocurence ofbleeding / periodsTimepoint: ocurence ofbleeding / periods in first treatment cycle at 30th day,60th day and 120th day
- Secondary Outcome Measures
Name Time Method regulation of bleeding patternTimepoint: regulation of bleeding pattern in three cycles;regulation of normal bleeding pattern /occurence of bleedingTimepoint: regulation of normal bleeding pattern at 30th day,60 th day and at 120th day